Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, ...

El Hospital Sant Joan de Déu Palma-Inca ha participado en un ensayo clínico a nivel nacional que evalúa la efectividad de la realidad virtual como herramienta innovadora de entrenamiento para ...

FDA approval positions Titan Prime as Coloplast’s updated IPP option for men with severe erectile dysfunction seeking long-term prosthetic restoration of erectile function. Improved flaccid ...

¿En qué bolsa de valores cotiza Coloplast A acc.? Las acciones de Coloplast A cotizan y se negocian en la bolsa de valores OTC. ¿Cuál es el símbolo bursátil o ...

Coloplast has named former Johnson & Johnson executive Gavin Wood as CEO, filling a vacancy that was open for 10 months. Former CEO Kristian Villumsen left the manufacturer of ostomy, continence, ...

The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and Chief Executive Officer (CEO) of the Coloplast Group, effective May 1, 2026. Gavin Wood ...

El hospital constituye una referente Unidad de Investigación Enfermera conformada por siete doctores y doctorandos, vinculada a la universidad y seleccionada por el prestigioso proyecto 'Nursing ...

Today, Coloplast is announcing changes to the company's Executive Leadership Team (ELT). The changes relate to the company's Interventional Urology business as well as the global People & Culture ...

Coloplast is now rated a cautious 'Buy,' as its valuation has become more reasonable after a significant price correction. Coloplast continues to deliver solid organic growth, boasts a wide economic ...

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail. Coloplast was founded on passion, ambition, and commitment ...

Coloplast announced that CEO Kristian Villumsen has stepped down from his role as of today. Former CEO Lars Rasmussen, who had been chair of the board, will become the interim CEO for the next 12 ...